Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
12
KOAN Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
69.18%
Day range:
$0.0018 - $0.0038
52-week range:
$0.0006 - $0.0235
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
--
Volume:
51.9M
Avg. volume:
3.9M
1-year change:
-20%
Market cap:
$540K
Revenue:
$1.9M
EPS (TTM):
-$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
KOAN
Resonate Blends, Inc.
|
-- | -- | -- | -- | -- |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -9.65% | -37.91% | $12.3077 |
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.04% | -- | $36.00 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 272.5% | -33.67% | $2.20 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
KOAN
Resonate Blends, Inc.
|
$0.0024 | -- | $540K | -- | $0.00 | 0% | 0.22x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8700 | $12.3077 | $213.4M | -- | $0.00 | 0% | 194.60x |
|
ELMD
Electromed, Inc.
|
$29.40 | $36.00 | $245.2M | 31.63x | $0.00 | 0% | 3.92x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.91 | $14.20 | $181.2M | 34.07x | $0.00 | 0% | 1.34x |
|
VNRX
VolitionRX Ltd.
|
$0.29 | $2.20 | $35.1M | -- | $0.00 | 0% | 19.58x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.72 | $1.50 | $100.8M | 70.59x | $0.00 | 0% | 0.79x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
KOAN
Resonate Blends, Inc.
|
-2526.9% | 11.132 | 164.16% | 0.03x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
ELMD
Electromed, Inc.
|
-- | 1.105 | -- | 4.58x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
KOAN
Resonate Blends, Inc.
|
$353.3K | -$538.1K | -500.61% | -- | -126.94% | $369.9K |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Resonate Blends, Inc. vs. Competitors
-
Which has Higher Returns KOAN or CATX?
Perspective Therapeutics, Inc. has a net margin of -176.24% compared to Resonate Blends, Inc.'s net margin of -12425.36%. Resonate Blends, Inc.'s return on equity of -- beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital KOANResonate Blends, Inc.83.35% -$0.00 -$172.5K CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About KOAN or CATX?
Resonate Blends, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 328.84%. Given that Perspective Therapeutics, Inc. has higher upside potential than Resonate Blends, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Resonate Blends, Inc..
Company Buy Ratings Hold Ratings Sell Ratings KOANResonate Blends, Inc.0 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is KOAN or CATX More Risky?
Resonate Blends, Inc. has a beta of 3.944, which suggesting that the stock is 294.363% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock KOAN or CATX?
Resonate Blends, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Resonate Blends, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KOAN or CATX?
Resonate Blends, Inc. quarterly revenues are $423.9K, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Resonate Blends, Inc.'s net income of -$747.1K is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Resonate Blends, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Resonate Blends, Inc. is 0.22x versus 194.60x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KOANResonate Blends, Inc.0.22x -- $423.9K -$747.1K CATXPerspective Therapeutics, Inc.194.60x -- $209K -$26M
-
Which has Higher Returns KOAN or ELMD?
Electromed, Inc. has a net margin of -176.24% compared to Resonate Blends, Inc.'s net margin of 12.65%. Resonate Blends, Inc.'s return on equity of -- beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital KOANResonate Blends, Inc.83.35% -$0.00 -$172.5K ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About KOAN or ELMD?
Resonate Blends, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 22.45%. Given that Electromed, Inc. has higher upside potential than Resonate Blends, Inc., analysts believe Electromed, Inc. is more attractive than Resonate Blends, Inc..
Company Buy Ratings Hold Ratings Sell Ratings KOANResonate Blends, Inc.0 0 0 ELMDElectromed, Inc.4 0 0 -
Is KOAN or ELMD More Risky?
Resonate Blends, Inc. has a beta of 3.944, which suggesting that the stock is 294.363% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.266, suggesting its less volatile than the S&P 500 by 73.442%.
-
Which is a Better Dividend Stock KOAN or ELMD?
Resonate Blends, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Resonate Blends, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KOAN or ELMD?
Resonate Blends, Inc. quarterly revenues are $423.9K, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Resonate Blends, Inc.'s net income of -$747.1K is lower than Electromed, Inc.'s net income of $2.1M. Notably, Resonate Blends, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 31.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Resonate Blends, Inc. is 0.22x versus 3.92x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KOANResonate Blends, Inc.0.22x -- $423.9K -$747.1K ELMDElectromed, Inc.3.92x 31.63x $16.9M $2.1M
-
Which has Higher Returns KOAN or INFU?
InfuSystem Holdings, Inc. has a net margin of -176.24% compared to Resonate Blends, Inc.'s net margin of 6.19%. Resonate Blends, Inc.'s return on equity of -- beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital KOANResonate Blends, Inc.83.35% -$0.00 -$172.5K INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About KOAN or INFU?
Resonate Blends, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 59.37%. Given that InfuSystem Holdings, Inc. has higher upside potential than Resonate Blends, Inc., analysts believe InfuSystem Holdings, Inc. is more attractive than Resonate Blends, Inc..
Company Buy Ratings Hold Ratings Sell Ratings KOANResonate Blends, Inc.0 0 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is KOAN or INFU More Risky?
Resonate Blends, Inc. has a beta of 3.944, which suggesting that the stock is 294.363% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock KOAN or INFU?
Resonate Blends, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Resonate Blends, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KOAN or INFU?
Resonate Blends, Inc. quarterly revenues are $423.9K, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Resonate Blends, Inc.'s net income of -$747.1K is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Resonate Blends, Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 34.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Resonate Blends, Inc. is 0.22x versus 1.34x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KOANResonate Blends, Inc.0.22x -- $423.9K -$747.1K INFUInfuSystem Holdings, Inc.1.34x 34.07x $36.5M $2.3M
-
Which has Higher Returns KOAN or VNRX?
VolitionRX Ltd. has a net margin of -176.24% compared to Resonate Blends, Inc.'s net margin of -862.39%. Resonate Blends, Inc.'s return on equity of -- beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital KOANResonate Blends, Inc.83.35% -$0.00 -$172.5K VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About KOAN or VNRX?
Resonate Blends, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 670.04%. Given that VolitionRX Ltd. has higher upside potential than Resonate Blends, Inc., analysts believe VolitionRX Ltd. is more attractive than Resonate Blends, Inc..
Company Buy Ratings Hold Ratings Sell Ratings KOANResonate Blends, Inc.0 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is KOAN or VNRX More Risky?
Resonate Blends, Inc. has a beta of 3.944, which suggesting that the stock is 294.363% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock KOAN or VNRX?
Resonate Blends, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Resonate Blends, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KOAN or VNRX?
Resonate Blends, Inc. quarterly revenues are $423.9K, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Resonate Blends, Inc.'s net income of -$747.1K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Resonate Blends, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Resonate Blends, Inc. is 0.22x versus 19.58x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KOANResonate Blends, Inc.0.22x -- $423.9K -$747.1K VNRXVolitionRX Ltd.19.58x -- $627.3K -$5.4M
-
Which has Higher Returns KOAN or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -176.24% compared to Resonate Blends, Inc.'s net margin of 3.93%. Resonate Blends, Inc.'s return on equity of -- beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital KOANResonate Blends, Inc.83.35% -$0.00 -$172.5K XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About KOAN or XTNT?
Resonate Blends, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 108.33%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Resonate Blends, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Resonate Blends, Inc..
Company Buy Ratings Hold Ratings Sell Ratings KOANResonate Blends, Inc.0 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is KOAN or XTNT More Risky?
Resonate Blends, Inc. has a beta of 3.944, which suggesting that the stock is 294.363% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.
-
Which is a Better Dividend Stock KOAN or XTNT?
Resonate Blends, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Resonate Blends, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KOAN or XTNT?
Resonate Blends, Inc. quarterly revenues are $423.9K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Resonate Blends, Inc.'s net income of -$747.1K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Resonate Blends, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 70.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Resonate Blends, Inc. is 0.22x versus 0.79x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KOANResonate Blends, Inc.0.22x -- $423.9K -$747.1K XTNTXtant Medical Holdings, Inc.0.79x 70.59x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
70
RGC alert for Jan 8
Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.
Buy
64
RVMD alert for Jan 8
Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.
Sell
38
CRNX alert for Jan 8
Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.
